Bioiasis AD (XBUL:BIOA) Other Current Receivables: €18.35 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:BIOA Bioiasis AD XBUL:BIOA
12 GF Score
Price €8.25
! 1 Warning Sign
View Full Analysis

What is Bioiasis AD Other Current Receivables?

Bioiasis AD XBUL:BIOA 12 Other Current Receivables is €18.35 Mil as of Sep. 2025. GuruFocus rates XBUL:BIOA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Bioiasis AD's Other Current Receivables for the quarter that ended in Sep. 2025 was €18.35 Mil.

Bioiasis AD's quarterly Other Current Receivables declined from Dec. 2024 (€5.75 Mil) to Jun. 2025 (€5.59 Mil) but then increased from Jun. 2025 (€5.59 Mil) to Sep. 2025 (€18.35 Mil).

Bioiasis AD's annual Other Current Receivables increased from Dec. 2022 (€-0.11 Mil) to Dec. 2023 (€3.07 Mil) and increased from Dec. 2023 (€3.07 Mil) to Dec. 2024 (€5.75 Mil).

Bioiasis AD Other Current Receivables Related Terms

Bioiasis AD Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Bioiasis AD's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioiasis AD Other Current Receivables Chart

Bioiasis AD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.11 3.07 5.75

Bioiasis AD Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 6.55 5.75 5.59 18.35
XBUL:BIOA
12GF Score
Bioiasis AD XBUL:BIOA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioiasis AD Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €18.35 Mil mean?
Bioiasis AD (XBUL:BIOA) has a Other Current Receivables of €18.35 Mil as of Sep. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bioiasis AD and its competitors.
Is Bioiasis AD's Other Current Receivables too high?
Bioiasis AD's current Other Current Receivables is €18.35 Mil. Overall, Bioiasis AD has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioiasis AD's Other Current Receivables compare to ABT and SYK?
Bioiasis AD's Other Current Receivables of €18.35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bioiasis AD and its competitors. Bioiasis AD's current Other Current Receivables is €18.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioiasis AD stock overvalued right now?
Bioiasis AD (XBUL:BIOA) has a current Other Current Receivables of €18.35 Mil. The current Other Current Receivables is €18.35 Mil. Bioiasis AD's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Bioiasis AD (XBUL:BIOA), the current Other Current Receivables is €18.35 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioiasis AD Business Description

Address 60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
12GF Score

Get the complete analysis for XBUL:BIOA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.25
Price